Description
Product Description:
Niraparix is a once-daily oral medication used for maintenance treatment in women with recurrent ovarian, fallopian tube, or primary peritoneal cancer if the cancer comes back. Niraparix is the first and only once-daily PARP inhibitor used after the cancer responds (complete or partial response) to platinum-based chemotherapy.
Features:
Product Name Niraparib
Common name Niraparib
Preparation capsule
Available strength 100 mg
Registerable
Reviews
There are no reviews yet.